The first-in-human phase 1/2 study of TSN1611, a highly selective KRAS G12D inhibitor, in patients with advanced solid tumors. Seizure-related homolog 6 (SEZ6) expression and ctDNA methylation ...
In a study published in Nature Methods, a research group led by Prof. YE Mingliang from the Dalian Institute of Chemical Physics of the Chinese Academy of Sciences (CAS), collaborating with Prof. LUO ...
A team led by Cedars-Sinai Health Sciences University investigators has created a faster, cheaper way to determine the genes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results